ArticleBritish journal of cancer2021

Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition.

Ganesh Pai Bellare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.